
Keywords: Correlate of risk; Biomarker; mRNA; Study design; Tuberculosis; 3HP; 12-dose once-weekly rifapentine 900Â mg plus isoniazid 900Â mg; ACS; Adolescent Cohort Study; COR; correlate of risk; CORTIS; Correlate of Risk Targeted Intervention Study; IGRA; interfe